Literature DB >> 2143884

Expression and distribution of atrial natriuretic polypeptide in the ventricles of children with myocarditis and/or myocardial infarction secondary to Kawasaki disease: immunohistochemical study.

T Fujiwara1, H Fujiwara, G Takemura, M Mukoyama, Y Saito, K Nakao, H Imura, M Nakano, K Baba.   

Abstract

We studied the expression and distribution of atrial natriuretic polypeptide in the ventricles of 27 autopsied children with Kawasaki disease. Fourteen of the children had died in the acute stage of the disease. Three without any coronary artery aneurysms died due to myocarditis, while 11 with coronary artery aneurysms also had myocarditis but died of coronary heart disease. Histologic evidence of acute myocardial infarction was noted in three children who died of coronary heart disease. In the 14 children with acute-stage deaths, no abnormal expression of atrial natriuretic polypeptide was noted in the ventricles, despite the presence of heart failure in seven of them for 2 to 22 days before death. The other 13 patients had coronary artery aneurysms and died in the healed stage. In three patients with granulation tissue and congestive heart failure, myocytes in foci around the granulations were moderate to markedly positive for atrial natriuretic polypeptide. These three patients died over 8 days after the onset of their first myocardial infarct. Of 10 patients with old myocardial infarction, four had a history of congestive heart failure. They demonstrated moderate or marked atrial natriuretic polypeptide expression in extensive regions around sites of massive fibrosis, and foci of slight expression in the inner third of the noninfarcted region of the ventricle. In the other six patients without congestive heart failure, there was slight or moderate expression in foci around sites of massive fibrosis. We concluded that the expression of atrial natriuretic polypeptide appeared more than 1 week after the onset of acute myocardial infarction in the ventricles of children with Kawasaki disease who died in the healed stage.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143884     DOI: 10.1016/0002-8703(90)90019-t

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  5 in total

1.  Ventricular expression of atrial and brain natriuretic peptides in dilated cardiomyopathy. An immunohistocytochemical study of the endomyocardial biopsy specimens using specific monoclonal antibodies.

Authors:  K Hasegawa; H Fujiwara; K Doyama; M Mukoyama; K Nakao; T Fujiwara; H Imura; C Kawai
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

2.  Cardiovascular biomarkers in acute Kawasaki disease.

Authors:  Yuichiro Z Sato; Delaram P Molkara; Lori B Daniels; Adriana H Tremoulet; Chisato Shimizu; John T Kanegaye; Brookie M Best; James V Snider; Jeffrey R Frazer; Alan Maisel; Jane C Burns
Journal:  Int J Cardiol       Date:  2011-07-20       Impact factor: 4.164

3.  Hyponatremia and syndrome of inappropriate antidiuretic hormone secretion in kawasaki disease.

Authors:  Goh-Woon Lim; Mina Lee; Hae Soon Kim; Young Mi Hong; Sejung Sohn
Journal:  Korean Circ J       Date:  2010-10-31       Impact factor: 3.243

4.  Divergent pathways mediate the induction of ANF transgenes in neonatal and hypertrophic ventricular myocardium.

Authors:  K U Knowlton; H A Rockman; M Itani; A Vovan; C E Seidman; K R Chien
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

Review 5.  Mercury promotes catecholamines which potentiate mercurial autoimmunity and vasodilation: implications for inositol 1,4,5-triphosphate 3-kinase C susceptibility in kawasaki syndrome.

Authors:  Deniz Yeter; Richard Deth; Ho-Chang Kuo
Journal:  Korean Circ J       Date:  2013-09       Impact factor: 3.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.